The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia
Nora E. Straznicky(Baker Heart and Diabetes Institute), Gavin Lambert(Swinburne University of Technology), Élisabeth Lambert(Swinburne University of Technology), Katrina L. Richards(Baker Heart and Diabetes Institute), Mariee T. Grima(Baker Heart and Diabetes Institute), Eldho Paul(Monash Health), Markus P. Schlaich(The University of Western Australia), Paul J. Nestel(Baker Heart and Diabetes Institute), Kazuko Masuo(Baker Heart and Diabetes Institute), John B. Dixon(Swinburne University of Technology), Carolina I. Sari(Baker Heart and Diabetes Institute), Nina Eikelis(Baker Heart and Diabetes Institute), Tye Dawood(Baker Heart and Diabetes Institute), Murray Esler(Baker Heart and Diabetes Institute)
Cited by 21
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k